Biotechnology & Medical Research

(Reuters) - Europe's drug regulator said on Tuesday it had begun reviewing AstraZeneca Plc's application for antibody-based COVID-19 therapy, a...

SHANGHAI (Reuters) - China has granted approval to five COVID-19 antigen kits made by local companies to be used for...

By Manas Mishra (Reuters) - The Russian invasion of Ukraine has left drugmakers scrambling to find ways for patients enrolled...

By Reuters Staff WASHINGTON (Reuters) - The United States on Wednesday denied renewed Russian accusations that Washington was operating biowarfare...

By Kanishka Singh (Reuters) - A 57-year-old man with terminal heart disease who made history as the first person to...

BEIJING (Reuters) - China is giving COVID-19 booster vaccines using technologies different from the initial injections, in an effort to...

(Reuters) - British researchers led by Oxford University said on Friday that the current understanding of long COVID and options...

By Riham Alkousaa BERLIN (Reuters) - Benedikt Richter, a 40-year-old teacher in the southwest German city of Kaiserslautern, long held...

By Carl O'Donnell, Francesco Guarascio and Neil Jerome Morales (Reuters) -Novavax Inc has delivered just a small fraction of the...

(Reuters) -British researchers want to repurpose existing antiviral therapies to treat COVID-19, the University of Oxford said on Friday, in...

TAIPEI (Reuters) - Taiwan's gift of 150,000 doses of its domestically developed Medigen COVID-19 vaccine has arrived in Somalia's breakaway...

TAIPEI (Reuters) -Taiwan Vice President William Lai used his final day in the United States to repeat an accusation that...

JERUSALEM (Reuters) - Israel on Wednesday broadened eligibility for a fourth dose of COVID-19 vaccine to include adults under 60...

JAKARTA (Reuters) - Indonesia kicked off its COVID-19 booster programme for the general public on Wednesday, as the world's fourth-most-populous...

By Gram Slattery and Augustin Geist RIO DE JANEIRO/BUENOS AIRES (Reuters) - Throughout much of 2020 and early 2021, South...

BENGALURU (Reuters) - India has approved Merck's COVID-19 pill and two more vaccines for emergency use as the world's second...

ABUJA (Reuters) - The Nigerian president's top media aide Garba Shehu said on Saturday that he has tested positive for...

ZURICH (Reuters) - Austria should offer some healthcare staff and other key workers a fourth COVID-19 jab, the National Vaccination...

(Reuters) - Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron...

COPENHAGEN (Reuters) - Getting a third dose of either Pfizer-BioNTech's or Moderna's COVID-19 vaccine offers a "significant increase" in protection...